Select for export Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/bmjopen-2022-068884 PubMed 37142308 Copy citation Copy BibTeX BMJ Open 2023-04-30 Alan K. Davis, Adam W. Levin, Paul Nagib, Stacey B. Armstrong, Rafael Lancelotta OpenAlex Published psilocybin AnxietyPTSDChronic Pain Clinical Trial More
Select for export Development and psychometric validation of a novel scale for measuring ‘psychedelic preparedness’ Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2023-04-27 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin WellbeingHealthcare Workers Qualitative Study More
Select for export Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1178529 PubMed 37181888 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-04-24 Terence H. W. Ching, Rachael Grazioplene, Calvin Bohner, Stephen A. Kichuk, Giuliana DePalmer, Elizabeth J. D’Amico OpenAlex Published psilocybin OCDChronic PainBrain Imaging Randomized Controlled Trial More
Select for export A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231167848 PubMed 37122239 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-04-24 Brandon Weiss, David Erritzøe, Bruna Giribaldi, David Nutt, Robin Carhart-Harris OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export A Phase I trial to inform clinical protocols for the safe administration of psilocybin-assisted psychotherapy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2023.04.12.23288325 Copy citation Copy BibTeX medRxiv 2023-04-18 Bennett JN, Blough MD, Mitchell I, Galloway L, Bains R. medRxiv PREPRINT (not peer reviewed) psilocybin Mystical ExperienceClinical TrialSafety Clinical Trial More
Select for export Use of Selective Alternative Therapies for Treatment of OCD. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2147/ndt.s403997 PubMed 37041856 Copy citation Copy BibTeX Unknown journal 2023-04-04 Khan I, Jaura TA, Tukruna A, Arif A, Tebha SS, Nasir S Europe PMC Published psilocybin OCDMechanism of ActionClinical Trial Systematic Review More
Select for export Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2023.109528 PubMed 37015315 Copy citation Copy BibTeX Unknown journal 2023-04-01 Zia FZ, Baumann MH, Belouin SJ, Dworkin RH, Ghauri MH, Hendricks PS Europe PMC Published psilocybin DepressionAddictionChronic Pain Clinical Trial More
Select for export The need for establishing best practices and gold standards in psychedelic medicine. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jad.2023.03.083 PubMed 37003433 Copy citation Copy BibTeX Unknown journal 2023-03-29 Feduccia A, Agin-Liebes G, Price CM, Grinsell N, Paradise S, Rabin DM. Europe PMC Published psilocybin DepressionPTSDClinical Trial Clinical Trial More
Select for export [Contribution of serotonin 5-HT2A receptor to antidepressant effect of serotonergic psychedelics]. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1254/fpj.22141 PubMed 36990794 Copy citation Copy BibTeX Unknown journal 2023-03-28 Ibi D. Europe PMC Published psilocybin DepressionAnxietyAddiction Review Article More
Select for export Experts to Discuss the Ethics of Psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2023.04.3.10 Copy citation Copy BibTeX Psychiatric News 2023-03-26 Terri D’Arrigo OpenAlex Published psilocybin Addiction Other More
Select for export Role of Psychedelics in Treatment-Resistant Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.psc.2023.02.004 PubMed 37149346 Copy citation Copy BibTeX Unknown journal 2023-03-24 Kamal S, Jha MK, Radhakrishnan R. Europe PMC Published psilocybin DepressionTreatment-Resistant Depression Other More
Select for export Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/cells12060963 PubMed 36980303 Copy citation Copy BibTeX Unknown journal 2023-03-21 Domanegg K, Sommer WH, Meinhardt MW. Europe PMC Published psilocybin AddictionNeuroplasticityMechanism of Action Clinical Trial More
Select for export Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231154852 PubMed 36938991 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-03-19 Jordan Sloshower, Patrick D. Skosnik, Hamideh Safi-Aghdam, Surbhi Pathania, Shariful A. Syed, Brian Pittman OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2023-03-16 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin OCDPharmacologyMechanism of Action Clinical Trial More
Select for export The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/molecules28062624 PubMed 36985596 Copy citation Copy BibTeX Molecules 2023-03-13 Timur Zanikov, Marta Gerasymchuk, Esmaeel Ghasemi Gojani, Gregory Ian Robinson, Shima Asghari, Alyssa Groves OpenAlex Published psilocybin DepressionPTSDPharmacology Animal Study More
Select for export Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1123424 PubMed 36998623 Copy citation Copy BibTeX Unknown journal 2023-03-13 Brett J, Knock E, Korthuis PT, Liknaitzky P, Murnane KS, Nicholas CR Europe PMC Published psilocybin AddictionClinical TrialReview Article Clinical Trial More
Select for export Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2023.109504 PubMed 36921889 Copy citation Copy BibTeX Unknown journal 2023-03-12 Wulff AB, Nichols CD, Thompson SM. Europe PMC Published psilocybin DepressionNeuroplasticityMechanism of Action Clinical Trial More
Select for export Understanding psychedelic 'mystical experience'-A case example Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/dh92g Copy citation Copy BibTeX PsyArXiv 2023-03-09 Turkia M. PsyArXiv PREPRINT (not peer reviewed) psilocybin Mystical ExperienceClinical TrialHealthcare Workers Clinical Trial More
Select for export Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/t6k9b Copy citation Copy BibTeX PsyArXiv 2023-03-09 Turkia M. PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionPTSDClinical Trial Clinical Trial More
Select for export Understanding psychedelic 'mystical experience'-A case example Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2023-03-09 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin AnxietyPTSDWellbeing Clinical Trial More
